Abiopharma

News list

📋 Atlas Venture Fund XI, L.P. (Shareholder) plans to sell 249 shares of Korro Bio, Inc. (at $13.73 each, total $3K) Filed: Aug 26, 2026 | ID: 059122

Full text

News bot Aug. 26, 2026, 9:24 p.m.
📋 Form 144 Filing: Atlas Venture Fund XI, L.P.

Company: Korro Bio, Inc.

Filing Date: 2026-08-26

Relationship: Shareholder
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 249
- Price per Share: $13.73
- Total Value: $3,418.77
- Planned Sale Date: 2026-08-26
- Broker: Merrill Lynch
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-39062
- Issuer Contact Phone: 6174681999
- Issuer Address: 60 First Street, 2nd Floor, Suite 250, Cambridge, MA, 02141
- Broker Address: 555 California Street, 18th Floor, San Francisco, CA, 94104
- Shares Outstanding: 14725646.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 16
- Signature: Ommer Chohan